Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Work Medical Technology Group Inc. (WOK:NASDAQ), powered by AI.
Work Medical Technology Group Inc. is currently trading at $3.92. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Work Medical Technology Group Inc. on Alpha Lenz.
View Work Medical Technology Group Inc.'s valuation metrics on Alpha Lenz.
“Work Medical Technology Group Inc.'s ROE is -6.8%. Explore profitability and growth together.”
Ask for details →Work Medical Technology Group Inc. operates as a prominent entity in the healthcare technology sector, focusing on developing and providing cutting-edge medical devices and solutions to enhance patient care. The primary function of this company is to innovate within the medical equipment landscape, offering advanced tools and technologies that support healthcare professionals in diagnostics, treatment, and patient management. Their product portfolio might include imaging systems, diagnostic machines, and surgical equipment, catering to a broad range of medical disciplines. Work Medical Technology Group Inc. plays a vital role in advancing healthcare delivery, improving precision in medical procedures, and potentially reducing the time and cost associated with patient treatment. The company's influence extends to hospitals, clinics, and research institutions, contributing significantly to the improvement of global healthcare standards. As a part of the financial markets, Work Medical Technology Group Inc. offers investors exposure to the evolving and growing healthcare and technology sectors, reflecting trends like increased healthcare spending and technological advancements in the medical field.
“Work Medical Technology Group Inc.'s ROE is -6.8%. Explore profitability and growth together.”
Ask for details →Work Medical Technology Group Inc. (ticker: WOK) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 216 employees.
The current price is $3.92 with a P/E ratio of -x and P/B of -x.
ROE is -6.81% and operating margin is -9.09%. Annual revenue is $10M.